FREQUENCY THERAPEUTICS INC (FREQ)
US35803L1089 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 40.85M | 51.95M | 79.64M | 220.30M | 200.20M | |||
| Marketable Securities | 25.80M | 31.14M | 51.07M | N/A | 17.20M | |||
| Receivables | N/A | 449.00K | 144.00K | 300.00K | 800.00K | |||
| Other Current Assets | 2.64M | 3.95M | 3.90M | 4.40M | 3.20M | |||
| Total Current Assets | 69.29M | 87.49M | 134.75M | 225.10M | 221.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 30.18M | 31.72M | 36.87M | 37.80M | 1.80M | |||
| Investments And Advances | N/A | 0.00 | 11.72M | N/A | N/A | |||
| Other Non-Current Assets | 2.03M | 2.03M | 2.02M | 1.80M | 100.00K | |||
| Total Non-Current Assets | 32.21M | 33.74M | 50.61M | 39.60M | 1.80M | |||
| TOTAL ASSETS | 101.50M | 121.24M | 185.36M | 264.70M | 223.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.67M | 10.00M | 833.00K | N/A | N/A | |||
| Accrued Expenses | 6.93M | 7.39M | 7.73M | 7.00M | 3.20M | |||
| Accounts Payable | 2.71M | 3.11M | 2.75M | 5.50M | 1.20M | |||
| Other Current Liabilities | 729.00K | 525.00K | 119.00K | 14.10M | 48.30M | |||
| Total Current Liabilities | 22.04M | 21.03M | 11.43M | 26.60M | 52.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 4.17M | 14.17M | 15.00M | 0.00 | |||
| Other Non-Current Liabilities | 26.21M | 26.85M | 28.94M | 30.60M | 3.10M | |||
| Total Non-Current Liabilities | 26.21M | 31.02M | 43.10M | 45.60M | 3.10M | |||
| TOTAL LIABILITIES | 48.25M | 52.04M | 54.53M | 72.20M | 55.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -281.21M | -261.67M | -180.09M | -95.40M | -68.90M | |||
| Additional Paid In Capital | 334.49M | 331.02M | 310.94M | 287.80M | 236.20M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 36.00K | 35.00K | 35.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -64.00K | -198.00K | -62.00K | 0.00 | 100.00K | |||
| Shares Outstanding | 35.75M | 35.26M | 34.61M | 34.00M | 31.20M | |||
| Tangible Book Value per Share | 1.49 | 1.96 | 3.78 | 5.66 | 5.37 | |||
| Total Shareholders' Equity | 53.25M | 69.19M | 130.82M | 192.50M | 167.40M | |||
| TOTAL LIABILITIES AND EQUITY | 101.50M | 121.24M | 185.36M | 264.70M | 223.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.06 | 0.11 | 0.08 | N/A | |||
| Current Ratio | 3.14 | 4.16 | 11.79 | 8.46 | 4.19 | |||
| Return On Assets (ROA) | -76.59% | -67.29% | -45.69% | -10.02% | -8.87% | |||
| Return On Equity (ROE) | -145.99% | -117.90% | -64.73% | -13.77% | -11.83% | |||
All data in USD